Table 3.
Variable | HIV-negative (%) | HIV-positive (%) | HIV status unknown (%) | P value (χ2) |
---|---|---|---|---|
Age group (years) | ||||
15–24 | 166 (26.8) | 58 (11.3) | 28 (18.1) | |
25–34 | 181 (29.2) | 156 (30.3) | 25 (29.0) | |
35–44 | 112 (18.1) | 181 (35.2) | 30 (19.4) | |
45–54 | 67 (10.8) | 86 (16.7) | 28 (18.1) | |
55–64 | 46 (7.4) | 23 (4.5) | 13 (8.4) | |
> 65 | 48 (7.7) | 11 (2.1) | 11 (7.1) | <0.001 |
Sex | ||||
Male | 395 (59.7) | 296 (53.8) | 94 (55.6) | |
Female | 267 (40.3) | 254 (46.2) | 75 (44.4) | 0.12 |
Referral facility | ||||
DOTS-linked facility | 423 (63.9) | 212 (42.8) | 75 (45.7) | |
Non DOTS-linked facility | 239 (36.1) | 283 (57.2) | 89 (54.3) | <0.001 |
TB confirmation | ||||
Bacteriological | 239 (36.1) | 172 (31.3) | 50 (29.6) | |
Clinical | 423 (63.9) | 378 (68.7) | 119 (70.4) | 0.11 |
TB site | ||||
Pulmonary | 406 (62.5) | 386 (72.3) | 120 (74.5) | |
Extra-pulmonary | 120 (18.5) | 71 (13.3) | 29 (18.0) | |
Both | 124 (19.1) | 77 (14.4) | 12 (7.5) | <0.001 |
Residence | ||||
Urban | 475 (71.8) | 383 (69.6) | 131 (77.5) | |
Rural | 187 (28.3) | 167 (30.4) | 38 (22.5) | 0.14 |
Previous TB treatment | ||||
No | 503 (76.0) | 395 (71.8) | 143 (84.6) | |
Yes | 159 (24.0) | 155 (28.2) | 26 (15.4) | 0.003 |
Treatment outcome | ||||
Cured | 178 (30.7) | 116 (23.9) | 34 (24.3) | |
Treatment completed | 192 (33.2) | 170 (35.1) | 5 (39.3) | |
Lost to follow-up | 81 (14.0) | 75 (15.5) | 33 (23.6) | |
Died | 111 (19.2) | 111 (22.9) | 15 (10.7) | |
Treatment failed | 17 (2.9) | 13 (2.7) | 3 (2.1) | 0.006 |